Clinical Trial Update: Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin with or without atezolizumab in Stage IV triple-negative breast cancer completed; results were posted in September 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Triple Negative Breast Cancer, Stage IV Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-09-13